Category Archives: Uncategorized

Patents and Misplaced Angst: Lessons for Translational Stem Cell Research from Genomics Debra J.H. Mathews1, Robert Cook-Deegan2 and Tania Bubela3, ,   1 Johns Hopkins Berman Institute of Bioethics, 1809 Ashland Avenue, Baltimore, MD 21205, USA 2 Institute for Genome Sciences & Policy and Sanford School of Public … Continue reading →

Media Contact: Leah Ramsay 202.642.9640 lramsay@jhu.edu EAST ASIA FACES UNIQUE CHALLENGES, OPPORTUNITIES FOR STEM CELL INNOVATION New Consensus Statement From The Hinxton Group Focuses On Japan, China Tension is the theme running through the new consensus statement issued by the Hinxton Group, an international working group … Continue reading →

Unsettled expectations: how recent patent decisions affect biotech Brenda M Simon & Christopher T Scott Nature Biotechnology 29, 229–230 (2011) doi:10.1038/nbt.1795 Published online: 09 March 2011 A look back shows that broad patents are a thing of the past and biotech inventors face heightened requirements … Continue reading →

In an opinion piece published on Feb. 10 in the journal Science, a team of scholars led by a Johns Hopkins bioethicist urges the scientific community to act collectively to stem the negative effects of patenting and privatizing of stem cell … Continue reading →

Statement on Policies and Practices Governing Data and Materials Sharing and Intellectual Property in Stem Cell Science [pdf] Recommendation 1a Establish a central hub for accessing global stem cell registry information Recommendation 1b Establish a central hub for accessing information … Continue reading →

I’d like to offer a sincere thank you to all of our Hinxton Group members for generously sharing your time and talents!  We will be in contact soon with the recommendations document, and look forward to continuing collaborations.

Courtesy of Jim Houlihan, here are links to useful resources that were mentioned during our meeting. Patent landscaping in stem cells which sits on the UK stem cell network site – clearly this can be configured on global data sets. … Continue reading →

NY Times, October 29, 2010 Reversing a longstanding policy, the federal government said on Friday that human and other genes should not be eligible for patents because they are part of nature. The new position could have a huge impact … Continue reading →

Two new publications from the UK IPO–commissioned by the Strategic Advisory Board for Intellectual Property Policy (SABIP) before its dissolution in August (Independent reports from leading academics). The Flow of Knowledge from the Academic Research Base into the Economy: the … Continue reading →

Stanford Journal of Law, Science and Policy: “Stem Cell Patents in a Global Economy: The Legal Challenges” This paper reviews recent developments in the international legal landscape on stem cell patents and compares the fate of one of the early … Continue reading →